NVX-COV2373 ADJUVATED LIPID NANOPARTICLE
UNII 2SCD8Q63PF

Substance Identification & Data

This profile provides standardized clinical and technical data for Nvx-cov2373 Adjuvated Lipid Nanoparticle, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2SCD8Q63PF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
2SCD8Q63PF
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
NVX-COV2373 ADJUVATED LIPID NANOPARTICLE
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
specifiedSubstanceG1
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Nvx-cov2373 Adjuvated Lipid Nanoparticle. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

NOVAVAX VACCINE
NVX-COV2373 ADJUVATED LIPID NANOPARTICLE

Brand / Trade Names

COVOVAX

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record